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Multiple trait measurements in 43 inbred mouse strains capture 
the phenotypic diversity characteristic of human populations 
 
 
Karen L. Svenson, Randy von Smith, Phyllis A. Magnani, Heather R. Suetin, Beverly Paigen, 












The breadth of genetic and phenotypic variation among inbred strains is often under 
appreciated because assessments include only a limited number of strains.  Evaluation of a larger 
collection of inbred strains provides not only a greater understanding of this variation, but 
collectively mimics much of the variation observed in human populations.  We used a high-
throughput phenotyping protocol to measure females and males of 43 inbred strains for body 
composition (weight, fat, lean tissue mass and bone mineral density), plasma triglycerides, HDL 
and total cholesterol, glucose, insulin, and leptin levels while mice consumed a high fat, high 
cholesterol diet. Mice were fed a chow diet until they were 6-8 weeks old, and then fed the high fat 
diet for an additional 18 weeks.  As expected, broad phenotypic diversity was observed among 
these strains.  Significant variation between the sexes was also observed for most traits measured.  
Additionally, the response to the high fat diet differed considerably among many strains.  By testing 
such a large set of inbred strains for many traits, multiple phenotypes can be considered 
simultaneously and thereby aid in the selection of certain inbred strains as models for complex 
human diseases.  These data are publicly available in the web accessible Mouse Phenome Database 
(http://www.jax.org/phenome), an effort established to promote systematic characterization of 
biochemical and behavioral phenotypes of commonly used and genetically diverse inbred mouse 
strains.  Data generated by this effort builds on the value of inbred mouse strains as a powerful tool 
for biomedical research.  
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Inbred strains and genetically engineered rodent models continue to provide invaluable tools 
for research aimed at improving human health through translation into prevention and treatment 
strategies.  With the current availability of annotated human, mouse and rat genomes (8, 16, 31, 33) 
comes a renewed interest in generating and accessing phenotypic data for maximal mining of 
genomic resources to understand both normal and disease processes.  What and where are the 
genomic perturbations that lead to disease in mammals?  How do genes interact to describe 
networks underlying these biological processes and pathways?  Providing comprehensive 
phenotype data sets for a large number of inbred mouse strains will enable use of a multi-
disciplinary approach to uncover these phenomena and to develop and test relevant animal models.  
In addition to reporting the availability of this data set to the scientific community, this paper 
summarizes some important phenotypic differences both among a large set of inbred strains and 
between sexes towards identifying mouse models of human disease. 
The Jackson Laboratory Heart, Lung, Blood and Sleep Program for Genomic Applications 
(JAX-PGA; http://pga.jax.org (29)) uses high throughput phenotyping to characterize both 
chemically-induced mutant mice and the large set of inbred strains prioritized by the Mouse 
Phenome Project, an international collaborative effort established to guide the characterization of 
biochemical and behavioral phenotypes of commonly used and genetically diverse inbred mouse 
strains in a systematic manner.  Results contributed by investigators world wide are deposited in the 
web accessible Mouse Phenome Database (MPD; http://www.jax.org/phenome).  The inception and 
development of the Mouse Phenome Project have been described previously (2, 9, 25).  All 
phenotyping criteria and detailed protocols accompany each submitted project, and the MPD web 
site offers on-line analysis tools.  The MPD currently contains over 600 measurements for 
phenotypes relevant to human health, including atherosclerosis, gallstones, hypertension, obesity, 
osteoporosis, airway hyperactivity, pain response, hematology and clotting, neurological, 
behavioral, and sensory disorders, alcoholism, and toxicity to environmental pollutants.  The MPD 
is continually updated with data from new studies. 
This paper summarizes a large amount of the phenotypic data collected from a set of 43 inbred 
strains of mice by the JAX-PGA and contributed to the MPD.  Numerous statistical and analytical 
tools are available as part of the MPD, and data sets held there are downloadable for further user-
based analyses.  We have analyzed measurements for body weight, lean and fat tissue mass, bone 
mineral density (BMD) and plasma glucose, lipids, insulin and leptin from a study to assess these 
parameters before and after mice consume a high fat and high cholesterol diet.  
 
 
Materials and Methods 
 
Mice and Diets 
 
Mouse strains were obtained from The Jackson Laboratory, Bar Harbor, Maine; names and 
abbreviations are shown in Table 1.  The sample size goal was 10 females and 10 males of each 
strain, but actual sample sizes varied from 4-26.  Mice were housed in specific pathogen free (SPF) 
barrier rooms with a 12 hour light:12 hour dark cycle (lights on from 6:00 am to 6:00 pm) in 
pressurized individually ventilated (PIV) cages (Maxi-Miser PIV; Thoren Caging Systems, Inc., 
Hazelton, PA) covered by snap-on filter tops (Reemay 2033, Thoren Caging Systems Inc., 
Hazelton, PA) and bedded with pine shavings (Crobb Box Co., Ellsworth, ME).  Mice had ad 
libitum access to food and acidified water.  Standard laboratory rodent chow (LabDiet 5K52, 
52 
 
LabDiet, Scott Distributing, Hudson, NH) was fed from weaning until mice were 6-8 weeks old and 
an atherogenic diet containing (by weight) 15% dairy fat (30% caloric content), 50% sucrose, 0.5% 
cholic acid, and 1.0% cholesterol (20) was fed for the next 18 weeks until they were 24-26 weeks 
old.  
In general, the same mice were tested for multiple phenotypes.  In cases when mice did not 
survive the 18-week protocol, additional mice were used to achieve a minimum number of four 
mice of each sex per strain for each measurement. 
 
 
Table 1.  The 43 inbred strains used in this study and their abbreviations.   
 
Strain             Abbreviation Strain            Abbreviation Strain        Abbreviation 
129S1/SvImJ 129S1 CBA/J CB NON/LtJ NON 
A/J A CE/J CE NZB/BlNJ NZB 
AKR/J AK CZECHII/EiJ CZECH2 NZW/LacJ NZW 
BALB/cByJ CBy *DBA/1J D1 PERA/EiJ PERA 
*BALB/cJ C DBA/2J D2 PL/J PL 
BTBR T+ tf/J BTBR FVB/NJ FVB PWK/PhJ PWK 
BUB/BnJ BUB I/LnJ I RIIIS/J R3 
C3H/HeJ C3 JF1/Ms JF1 *RF/J RF 
C57BL/10J B10 KK/HlJ KK SEA/GnJ SEA 
C57BL/6J B6 LP/J LP SJL/J SJL 
C57BLKS/J BKS MA/MyJ MA SM/J SM 
C57BR/cdJ BR MOLF/EiJ MOLF SPRET/Ei SPRET 
C57L/J L MSM/Ms MSM SWR/J SW 
C58/J C58 NOD/LtJ NOD WSB/EiJ WSB 
CAST/EiJ CAST     
 





The phenotyping protocol, developed as part of The JAX-PGA (http://pga.jax.org), is based 
on high throughput non-invasive strategies.  Table 2 summarizes the order in which measurements 
were obtained and the age of mice and duration of high fat diet consumption at the time of each 
measurement.  Data presented here include measurements pertinent to obesity, the metabolic 
syndrome and osteoporosis.  The complete protocol is available from the JAX-PGA web site, but 
details relevant to this report are as follows.  Mice were weaned when they were three weeks old 
and fed standard rodent chow containing 6% fat.  At 6-8 weeks old, following a four hour fast (7:00 
am to 11:00 am), blood was withdrawn from the retro-orbital plexus of each mouse through a 
heparin-coated hematocrit tube into a 1.5 ml Eppendorf tube containing 7.5 μl of sodium heparin 
(1000u/ml blood), and placed on ice.  Samples were centrifuged at 14,000 rpm for five minutes, and 
plasma was removed for measurement of total cholesterol, high-density lipoprotein (HDL) 
cholesterol, triglycerides and glucose.  Mice were then fed the atherogenic diet until they were 16 
weeks old, at which time their weight was measured and they were examined for bone mineral 
density and body composition by dual energy x-ray absorptiometry (DEXA).  Mice continued 
consuming the atherogenic diet for nine more weeks.  At age 24-26 weeks, having consumed the 
53 
 
atherogenic diet for 18 weeks, mice were weighed, fasted, and blood samples were collected as 
described above for analysis of plasma total cholesterol, HDL cholesterol, triglycerides and glucose.  
One week later, while mice continued to eat the atherogenic diet, blood samples (non-fasted) were 
collected for plasma leptin and insulin analyses, and mice were euthanized by C02 asphyxiation.  
All bleeds for leptin and insulin determinations were obtained between the hours of 1 and 2 pm.  
The Animal Care and Use Committee at The Jackson Laboratory approved all animal protocols.  
 
Table 2.  Protocol summary 
 
Age* Diet Weeks**  Phenotypes measured (units) 
 6 - 8 Chow 0 
 
Body weight (g), plasma cholesterol (mg/dL),  
HDL (mg/dL), glucose (mg/dL) 
16 Fat 8 
 
Body weight (g), bone density (mg/mm2),  
body fat (%), lean tissue mass (g) 
25 Fat 17 
 
Body weight (g), plasma cholesterol (mg/dL),  








Plasma leptin (ng/ml), insulin (ng/ml)  
 
*Age of mice in weeks.  **Number of weeks fed high fat diet.  HDL: high-density lipoprotein 
cholesterol.  Plasma was collected after mice were fasted for 4 hours in the morning, except for 





Phenotyping methods are briefly summarized here (details at http://pga.jax.org/protocols).  
Total plasma cholesterol, HDL-cholesterol (HDL), triglycerides, and glucose were measured using 
a Beckman Coulter Synchron CX5 Delta Chemistry Analyzer (Beckman Coulter, Inc., Fullerton, 
CA) according to the manufacturer’s instructions.  Plasma insulin and leptin levels were determined 
by ELISA (ALPCO Diagnostics, Windham, NH; CrystalChem, Inc., Downers Grove, IL).  Mice 
were weighed with an Ohaus Navigator scale set at “averaging weight” over a 15-second interval to 
correct for the constant motion of the mice.  Bone mineral density, percent body fat and lean tissue 
mass were determined using a Lunar PIXImus dual energy x-ray absorptiometry machine (DEXA; 
Lunar Corp. Madison, WI).  For DEXA analysis, mice were anesthetized with tribromoethanol at a 
dose of 0.02 ml/gram body weight.  Because the skull is so bone dense, the head was excluded from 
DEXA analyses.   
 
Mouse Phenome Database 
 
Data for all phenotypic measurements performed in this study on the strains listed in Table 1 
are available for on-line evaluation or downloading from the Mouse Phenome Database (19, 23).  
Prior to submission to the MPD, data were reviewed for completeness using a minimum 
requirement of four animals per sex per strain for each measurement.  Separate analyses were 
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performed for each sex.  Individual values exceeding 2 standard deviations from the group mean 
were eliminated.  This resulted in the loss of some strains for certain phenotypes.  The missing 
strains and phenotypes are listed in Table 3.  Strain CE was used only in leptin and insulin tests, and 
for many tests only one of the BALB strains (CBy or C) was used.  Data were obtained for at least 
36 strains for every phenotype measured.  To describe differences in phenotypes between sexes 
within each strain, the MPD analysis tool “Sex differences” was used.  In this analysis, a 
normalized sex difference is calculated for each strain as the average male value minus the average 
female value for a strain, divided by the average of male and female values. 
 
 
Table 3.  Strains not represented for some phenotypic measurements in this study.  
 




 F M 
 
Missing Strains 
Body Composition 39 38 CBy(f), CE, NZB(f), PL(m), PWK(m), 
R3(m), RF 
Lipids (after high fat diet) 40 36 AK(m), C, CE, I(m), KK(m), PL(m), 
PWK(f), RF(m) 
Glucose (after high fat diet) 42 39 AK(m), CE, KK(m), RF(m) 
Leptin 42 43 MA(f) 
Insulin 41 42 MA(f), MOLF(f), SPRET(m) 
    







The detailed data for each mouse is stored in MPD, which also has analysis tools and the 
ability to download data, so we encourage the investigator to visit the MPD web site.  As expected, 
broad diversity in phenotypes among strains was observed.  Strain averages as well as values for 
strains showing extreme high or low phenotypes are given in Table 4.  Significant sexual 
dimorphism was observed for most traits measured; hence the data are presented and analyzed 
separately for each sex.  The following paragraphs briefly describe sex and strain trends for each 
phenotype under high fat diet conditions. 
 
Body Composition.  Measurements obtained from the DEXA scan, including body weight, percent 
fat, lean tissue mass, and bone mineral density, were obtained from 16-week old mice fed the 
atherogenic diet for eight weeks and are shown in Figure 1. 
Body weight.  Considerable variation in body weight among the strains occurs with a 3.0 fold 
(females) and a 2.8 fold (males) difference between the smallest and largest strains.  Although most 
strains fall within one standard deviation (SD) of the overall mean (22.4 g for females; 27.9 g for 
males), six strains are more than one SD above the mean (AK, BTBR, NZW, both sexes; NON 
females; CBA, KK males) and seven strains are more than one SD below the mean (CAST, 













































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 1. Weight and body composition 
amond strains while consuming the 
high-fat diet. Values were obtained 
using dual-energy x-ray 
absorptiometry (DEXA) from mice 
aged 14-16 wk after they had 
consumed the high-fat diet for 8 wk. 
Values are means ± SE. Open bars are 
female values; solid bars are male 
values. A: body weight. B: percent fat. 
C: lean tissue mass. D: bone mineral 
density. For strain abbreviations, see 
Table 1. 
but one strain (PL) with low body 
weight are recently derived from the 
wild.  Males weighed more than 
females except in strains SPRET and 
NON, for which females weighed 15% 
and 6% more than their male 
counterparts, respectively. 
Percent fat.  The overall strain mean of 
23.3% fat is identical for females and 
males.  The difference between the 
leanest and fattest strains is 2.7 fold 
among females and 3.7 fold among 
males. Nine strains are more than one 
SD above the mean (AKR, CB, both 
sexes; JF1, NON, NZW, PERA, 
females; 129S1, KK, LP, males) and 
seven strains are more than one SD 
below the mean (C58, MOLF, SW, both 
sexes; CZECH2, WSB, females; B6, 
SPRET, males).  Females have higher 
percent fat than male counterparts in 21 
strains; the largest differences occur in 
strains SPRET and FVB (54% and 38% 
greater, respectively). Males have 
higher percent fat in 14 strains; the 
largest differences occur in strains KK, 
BR and 129S1 (56%, 35%, and 32% 
greater, respectively).  No sex difference is seen for this trait in MOLF. 
Lean tissue mass. Lean tissue mass varies 2.6 fold in females and 2.5 fold in males.  Seven strains 
are greater than one SD above the mean (AKR, BTBR, NZW, both sexes; BUB, KK, NON, 
females; NZB males) and seven strains are greater than one SD below the mean (CAST, CZECH2, 
MOLF, MSM, WSB, both sexes; PL females; SPRET males). Males have greater lean tissue mass 
than females in all strains except SPRET, which shows no sex difference. The greatest sex 
differences are seen in SM and FVB (males 41% and 38% greater than females, respectively). The 
wild-derived strains appear as low value outliers. 
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Fig. 2. Plasma lipids, glucose, leptin, and insulin among strains after consuming the high-fat diet. 
Lipid and glucose measurements (mg/dl) are for fasted animals at 23-25 wk of age after they had 
consumed the high-fat diet for 17 wk. Leptin and insulin (ng/ml) were measured in nonfasted 
animals age 24-26 wk after they had consumed the high-fat diet for 18 wk. Values are means ± 
SE. Open barss are female values; solid bars are male values. A: total cholesterol. B: high-density 
lipoprotein cholesterol. C: triglycerides. D: glucose. E: leptin. F: insulin. 
Bone mineral density. Bone mineral density (BMD) was the least variable of the body composition 
phenotypes measured. The difference between the strains with the most and least dense bones is 1.4 
fold for females and 1.5 fold for males. Strain means are not significantly different between females 
and males (0.0495 ± 0.005 for females; 0.0497 ± 0.005 for males). Sex differences do not exceed 
14% for any strain. Five strains are more than one SD above the mean (AKR, LP, NZW, both 
sexes; NZB, KK, males) and seven strains are more than one SD below the mean (CAST, CZECH2, 
MOLF, MSM, WSB, both sexes; SM, PWK, females). Except for strain SM, the strains with the 
lowest bone density are wild-derived. 
 
Plasma Lipids and Glucose. Plasma lipids (total and HDL cholesterol, triglycerides) and glucose 
were measured in fasted 25-week old animals fed the atherogenic diet for 17 weeks and are shown 
in Figure 2. Total cholesterol (Figure 2A) and HDL cholesterol (Figure 2B) are measured directly.  
An estimate of non-HDL cholesterol, which in the mouse consists of LDL and VLDL, may be 
obtained by subtracting HDL cholesterol from total cholesterol. The distribution of non-HDL 
cholesterol is available on MPD. 
Total cholesterol. Strain MOLF exhibited extremely high total plasma cholesterol (>2 SD above 
strain means) in both females (1235 ± 188 mg/dL) and males (2143 ± 392 mg/dL) after consuming 
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the high fat diet. Eight other strains have levels greater than 300 mg/dL, a level at which humans are 
treated with cholesterol-lowering drugs (A, C58, CAST, MA, NOD, NZB, both sexes; BR, females; 
JF1, males). To more accurately compare cholesterol values among strains after consuming the high 
fat diet, we removed MOLF and used average values of 243 ± 107 mg/dL for females and 244 ± 92 
for males.  Seven strains fall greater than one SD above the recalculated mean (A, C58, CAST, 
NOD, both sexes; MA, NZB, females; JF1, males) and six strains are greater than one SD below the 
strain mean (D1, CZECH2, MSM, both sexes; CB, D2, SJL, females). Males show higher total 
plasma cholesterol levels than females in 20 strains with the greatest differences in strains JF1, 
MOLF, SJL, D2, and CBA (58%, 53%, 50%, 42%, and 40%, respectively; Figure 2A). In 13 
strains, females have higher levels than males with the greatest differences in strains C58, R3, BUB, 
and MA (40%, 38%, 35%, and 32%, respectively). No sex differences were found in strains CAST 
and SW.  
HDL cholesterol. The average HDL cholesterol among all strains differs by only 10 mg/dL between 
the sexes (83.0 for females; 92.5 for males) although values are highly variable among sexes, with a 
difference in females of 4.9 fold and in males a remarkable 14.5 fold difference (Figure 2B). Five 
strains are more than one SD from the mean for all strains (MA, NOD, NZB, both sexes; PERA, 
females; 129S1, males) and three strains are greater than one SD below the mean (D1, CAST, I, 
females). Males of 35 strains have higher HDL on the high fat diet than female counterparts with 
differences exceeding 50% in strains CB, SEA, C3, and D1. In strain MOLF, females have a 
remarkable 136% higher HDL than males, reflecting the notable decrease in HDL levels observed 
in males. Levels of HDL are higher in females than males in 10 strains, with C58, PERA and NZB 
showing the greatest differences (39%, 23%, and 18%, respectively) after MOLF.  
Triglycerides. SPRET females have extremely high triglycerides after consuming the high fat diet 
(534 ± 409 mg/dL) and for comparisons we recalculated the strain mean for females after excluding 
this value and used 85 ± 50 mg/dL. Eight strains are greater than one SD above this recalculated 
mean (CAST, MOLF, MSM, both sexes; KK, PL, RF, females; NOD, SPRET, males) and only one 
strain, B6 males, is more than one SD below the mean. Five strains, all wild-derived, have values 
above 190 mg/dL which is considered high in humans (MSM, both sexes; CAST, MOLF, SPRET, 
males).  In 21 strains, males have higher triglyceride levels than their female counterparts and 
differences exceeded 30% in nine of them (Figure 2C) with strain NOD exhibiting the greatest 
difference (107%). In 14 strains females show higher values than males with strain SPRET showing 
an 87% higher value while other differences were less than 30%.  
Glucose. In strain NOD, a model of type I autoimmune diabetes, males have plasma glucose levels 
of 348 ± 237 mg/dL, exceeding the range for other strains, as expected (Figure 2D). With this value 
excluded, the recalculated strain mean for males is 159 ± 33.4 mg/dL. Seven strains have values 
greater than one SD above the recalculated mean (B6, CB, SPRET, both sexes; B10, females; NON, 
SM, males) and seven strains have levels greater than one SD below this mean (A, C, C58, MOLF, 
both sexes; 129S1, females; PERA, WSB, males). Plasma glucose levels for males in 27 strains 
other that NOD exceed that of females with NON and SM showing the greatest differences (63% 
and 32%, respectively) after NOD. In the 11 strains for which female values exceeded male values, 
differences are 20% or less. 
Response to high fat diet.  Baseline values for lipids and glucose, measured prior to mice beginning 
the high fat diet, are available for all strains from the MPD (19, 24). Figure 3 summarizes strain 
responses to the high fat diet for plasma total cholesterol, HDL cholesterol, triglycerides and 
glucose in panels A-D, respectively. Response is expressed as fold-increase in values compared to 
those measured in animals consuming standard chow. Since mice consumed the diet for 18 weeks, 
this would include any change induced by age as well as the response to diet. All strains show an 
increase in plasma total cholesterol for both sexes (average female increase = 3.5-fold; average 
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Fig. 3. Response to high-fat diet among strains. Values are expressed as fold increase from chow 
to those measured after mice consumed the high fat diet for 17 wk. Values are means ± SE. Open 
bars are female values; solid bars are male values. Fold increase is shown for total plasma 
cholesterol (A), HDL cholesterol (B), triglycerides (C), and glucose (D). 
male increase = 2.7-fold), ranging from 1.3-fold for D2 males to 24.3-fold in MOLF males.  HDL 
values differ by 1.5-fold in females and by 1.3-fold in males with some strains showing a slight 
decrease in values. Of note, however, is the remarkable decrease in HDL levels for MOLF males to 
only 20% of chow values. Triglycerides are generally lower after the high fat diet, although in five 
strains values increase by 1.5 to 5-fold. Glucose levels remain close to those on chow for both sexes 
in most strains with fold-increases ranging from 0.5 to 1.7.  
 
Leptin. Leptin levels, shown in Figure 2E, are highly variable with differences between extreme 
high and low values of 13.7 fold in females and 33.6 fold in males. Four strains are greater than one 
SD above the strain mean (KK, RF, both sexes; CE, females; LP, males) and three strains are more 
than one SD below the mean (MOLF, both sexes; CZECH2, females; CBy, males). Strain C shows 
the greatest sex difference with females having 128% higher levels than males. In 17 additional 
strains female values are greater than male values with notable differences for strains FVB, CBy, 
and PERA (95%, 93%, and 93%, respectively). In 23 strains, male values are greater than those of 
females with the greatest differences in strains BR, PL, and LP (107%, 92%, 71%, respectively).  
Strain SEA shows no difference in leptin levels between sexes. 
 
Insulin. Insulin (Figure 2F) varies 5.6 fold in females and 8.5 fold in males. Five strains are greater 
than one SD above the strain mean (D2, KK, both sexes; AK, CB, LP, males) and three strains are 
greater than one SD below the mean (A, PERA, MOLF, males). Males have greater values than 
females in all but six strains with differences exceeding 100% in strains BTBR, LP, and 129S1. In 
16 additional strains, male values exceed female values by greater than 50%.  In strains for which 
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H indicates the average strain value for a parameter is greater than one standard deviation 
above the overall strain mean; L indicates the average strain value is greater than one 
standard deviation below the overall mean.  Overall strain means were calculated 
separately for each sex.  *Phenotype profile follows that of the metabolic syndrome. 
female values are greater, PERA females have an 88% higher level than males, while other 
differences are less than 30%. 
 
 
Inbred Strains as Models 
 
To summarize the overall phenotypic state of the inbred strains used in this study after 18 
weeks consuming the high fat diet, strains with two or more average trait values lying above or 
below one standard deviation unit from strain means per sex are shown in Table 5.  
 
 
     Table 5.  Inbred strains with  2 extreme phenotypes after consuming the high fat diet. 
 
Strain Sex % Fat TG HDL GLU INS 
129S1 M H   H     
AK M H       H 
B6 M L     H   
C58 F, M L     L   
CAST* F   H L     
CB* F H     H   
CB* M H     H H 
KK F   H     H 
KK M H       H 
LP M H       H 
MOLF F, M L H   L   
MSM* F, M   H   H   
NOD M   H H H   
PERA  F H   H     
SPRET M L H   H   
 
In this summary we have focused on phenotypes prevalent in the metabolic syndrome, 
namely percent fat and plasma levels of triglycerides, HDL cholesterol and glucose and have also 
included insulin levels. For some strains only one sex exhibits extreme traits, but for many strains 
both sexes show extreme traits, although both sexes of a strain do not always share the same trait 
profile. For example, using risk factors for metabolic syndrome as defined by the American Heart 
Association (10) (e.g., elevated triglycerides, low HDL cholesterol, elevated glucose, obesity) three 
inbred strains from Table 5 can be readily identified as carrying two of these features: CAST 
females have high triglycerides and low HDL; CB females and males have increased fat with high 
glucose (CB males also have high insulin); MSM (both sexes) has high triglycerides and high 
glucose.  Strains with only one extreme metabolic syndrome-defined trait but also having high 
insulin levels are also included in Table 5 (AK, males; KK, both sexes; LP, males). This table aids 
in the practical consideration of inbred strains as models of complex human diseases such as the 
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metabolic syndrome, and such a table could also be constructed from relevant phenotype data to 
summarize other complex traits such as diabetes, obesity or cardiovascular disease. Such a list can 
also be generated for strains fed the standard chow diet. Other measurements available from MPD, 
such as systolic blood pressure (4, 7, 14, 30), can supplement this list, providing additional 






Laboratory mouse inbred strains are derived from a limited number of gene pools (27, 32), 
and the distribution of phenotypes across tens of inbred strains often shows a unimodel continuous 
variation, suggesting that we can treat them as a population. These distributions can then be 
interrogated for features that mimic human disease. The large amount of phenotype data presented 
here provides a basis for profiling inbred strains in the context of complex trait analysis and towards 
their development as experimental models. 
As the genetic structure of inbred mouse strains is revealed (5, 13, 35, 36), phenotypic 
information becomes an increasingly important element for understanding how genes drive disease 
processes. Environmental factors are also important gene regulators, and in this study mice were 
exposed to a high fat, high cholesterol diet as an environmental perturbation to which susceptibility 
to disease-related traits can be evaluated. Broad phenotypic diversity was observed among these 
inbred strains both in baseline (pre-diet) and, especially, in response to the dietary challenge.  
Moreover, sexual dimorphism among strains was observed for most traits measured. This 
observation underscores the necessity to account for sex in evaluating phenotype data and failure to 
do so may impact experimental conclusions (15). Many studies overcome this issue by using only 
one sex in an experimental design. However, in a large comprehensive study involving multiple 
phenotypic observations, a better understanding about pathways leading to disease is gained by 
testing both sexes.   
Some of the phenotypic variation observed between sexes may be attributable to the 
atherogenic diet, as is shown by comparing lipid and glucose values before and after high fat diet 
feeding. It is known that inbred strains vary in their susceptibility to diet-induced obesity (28, 34) 
and atherosclerosis (20, 22). Most strains had lower plasma triglyceride levels after consuming the 
high fat diet, and Rossmeisl and colleagues have suggested a role for respiratory uncoupling protein 
in this response (26). The five strains that did not follow this trend but rather showed increases in 
triglyceride levels may be useful for further investigation of this mechanism. Insulin and leptin 
levels, measured in this study after mice consumed the high fat diet for 18 weeks, were among the 
most variable traits we measured. Insulin levels have been shown to vary according to diet (1, 3) 
and circulating leptin levels are also affected by a high fat diet, especially in strains prone to diet-
induced obesity (1, 6). Hence, it is plausible that much of the variation we observed is in response 
to the high fat diet. 
Nine strains have total plasma cholesterol levels exceeding 300 mg/dL after consuming the 
high fat diet. One would expect that these strains would be susceptible to diet-induced 
atherosclerosis. However, only three of these strains (C58, both sexes; BR, females; A, males) 
develop significant aortic lesions in response to this diet (23); other strains appear to be resistant to 
lesion development. Interestingly, both females and males of strain A have total cholesterol levels 
above 500 mg/dL on the high fat diet while only males develop significant aortic lesions.  Strain 
MOLF, with cholesterol levels above 1000 mg/dL in both sexes, develops only modest lesions 
compared to more susceptible strains. Mice have high HDL compared to humans, likely due to their 
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inherent deficiency in cholesteryl ester transfer protein (12). Elevated HDL cholesterol may account 
for the high total cholesterol in three of the nine strains (MA, NOD, NZB), and may also contribute 
to their resistance to atherosclerosis. However, in the other strains with high cholesterol that are 
resistant to atherosclerosis, mechanisms independent of HDL level are likely to explain this 
protection. 
Mouse strains more recently developed for laboratory use from the wild have been an 
important tool for mapping genes by providing both phenotypic and genotypic diversity to the 
repertoire of available strains (11, 18). Our data identify many of these strains as having extreme 
phenotypes, such as the recurrence of strains CAST, CZECH2, MOLF, MSM, and WSB as low 
outliers for body composition parameters (weight, lean tissue mass, bone mineral density) and 
CAST, MOLF, MSM and SPRET comprising the high outliers for triglycerides. 
The great range of phenotypic variation among 43 inbred strains for the phenotypes 
measured in this study restates that multiple genes in concert direct an interplay contributing to 
complex disorders. This variation can be used to further investigate underlying processes and 
identify genes affecting these phenotypes by following their segregation when strains are mixed.  
We have provided evidence supporting the use of certain inbred strains for modeling human 
diseases such as obesity, diabetes, osteoporosis, and the metabolic syndrome. Does this range 
capture the diversity observed in humans? How well will these models represent human disease?  
By comparing typical normal human reference values (17) to the traits measured in mice in this 
study under both normal chow and high fat diet conditions, we have evaluated this assertion in 
Table 6. Values for mice on a normal chow diet were obtained from MPD (21).  The mouse data 
encompasses most of the normal or desirable human values and provides a realistic range of 
extreme values for the traits that we were able to compare. Mouse and human obesity are difficult to 
compare using weight data alone and a better estimate would be provided by a comparison of 
percent body fat, a measurement not readily available for humans. The range of glucose levels for 
mice is considered normal. By demonstrating such a broad range of response to consuming a high 
fat diet, we establish the utility of the laboratory mouse for dissecting important pathways 
controlling normal and disease processes implicated in the regulation of body composition, bone 
health, and lipid metabolism. Using rapidly emerging bioinformatics tools, investigators can begin 
to map these divergent phenotypes to genomic elements driving this diversity. 
 
Table 6.  Comparison of normal human values to the range of values represented among the set of 





Mouse Range (43 strains,   
normal chow diet) 
Mouse Range 
(43 strains, high fat diet) 
  Female Male Female Male Female Male 
 Body weight 150 lb 170 lb 12-30g 14-33g 12-35g 15-42g 
 Total cholesterol (mg/dL) 150-250 150-250 45-187 55-155 102-5571 135-5091 
 HDL cholesterol (mg/dL) 40-60 40-60 37-109 45-126 35-172 11-162 
 Triglycerides (mg/dL) 10-190 10-190 48-303 55-352 35-2632 36-249 
 Glucose (mg/dL) 70-110 70-110 108-230 127-268 85-2663 82-2323 
 Insulin (ng/mL) 0.2-1.0 0.2-1.0  ND ND 0.5-3.1 0.5-4.5 
 
1 Strain MOLF was excluded because of its extreme values (1235 mg/dL, females; 2134 mg/dL, males).  
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